Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • Anticancer Research
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • In Vivo
    • Anticancer Research
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
In Vivo
  • Other Publications
    • In Vivo
    • Anticancer Research
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
In Vivo

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • Anticancer Research
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Visit iiar on Facebook
  • Follow us on Linkedin

transarterial chemoembolization

  • Open Access
    Determinants of Survival of Ablation Treatment for Portal Vein Tumor Thrombus in Patients With Hepatocellular Carcinoma
    TORU ISHIKAWA, RYO SATO, RYO JIMBO, YUJI KOBAYASHI, TOSHIFUMI SATO, AKITO IWANAGA, TOMOE SANO, JUNJI YOKOYAMA and TERASU HONMA
    In Vivo September 2024, 38 (5) 2501-2505; DOI: https://doi.org/10.21873/invivo.13721
  • Open Access
    Volumetric Analysis of Hepatocellular Carcinoma After Transarterial Chemoembolization and its Impact on Overall Survival
    MONIKA HAJKOVA, TOMAS ANDRASINA, PETRA OVESNA, TOMAS ROHAN, MAREK DOSTAL, VLASTIMIL VALEK, LENKA OSTRIZKOVA, STEPAN TUCEK, JIRI SEDO and IGOR KISS
    In Vivo September 2022, 36 (5) 2332-2341; DOI: https://doi.org/10.21873/invivo.12964
  • You have access
    Progression After Molecular Targeted Agents: Hepatic Arterial Changes and Transarterial Chemoembolization in Hepatocellular Carcinoma
    NORITAKA MATSUDA, NORIHIRO IMAI, TEIJI KUZUYA, KENTA YAMAMOTO, TAKANORI ITO, YOJI ISHIZU, TAKASHI HONDA, MASATOSHI ISHIGAMI and MITSUHIRO FUJISHIRO
    In Vivo March 2021, 35 (2) 1185-1189; DOI: https://doi.org/10.21873/invivo.12367
In Vivo

© 2026 In Vivo

Powered by HighWire